Fisher R S, Cysyk B
Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205.
J Toxicol Clin Toxicol. 1988;26(7):477-86. doi: 10.3109/15563658809038563.
Carbamazepine is a drug of choice for partial epilepsies, certain affective disorders and neuralgic pain syndromes. It has an excellent safety record; however, overdose can be dangerous. This article reports one of the very few fatalities from carbamazepine overdosage, in an individual with a peak carbamazepine level of 54 mg/L. Manifestations of this and other major carbamazepine overdoses reviewed from the literature were similar to those of tricyclic - anticholinergic overdose, with coma, hypotension, respiratory depression, cardiac arrhythmias, abnormal movements and seizures. Fatality from cardiovascular causes occurred despite decline of serum carbamazepine levels to the putatively non-toxic range, emphasizing the potential for delayed consequences of carbamazepine overdosage. Management should consist of vigorous gastric lavage and installation of activated charcoal, full supportive care in a monitored setting and consideration of early charcoal hemoperfusion, before the patient becomes hypotensive.
卡马西平是治疗部分性癫痫、某些情感障碍及神经痛综合征的首选药物。它有着出色的安全记录;然而,过量服用可能会很危险。本文报告了极少数因卡马西平过量致死的案例之一,该患者卡马西平峰值水平达54毫克/升。本文及文献中回顾的其他主要卡马西平过量案例的表现与三环类抗胆碱能药物过量相似,包括昏迷、低血压、呼吸抑制、心律失常、异常运动和癫痫发作。尽管血清卡马西平水平已降至假定无毒范围,但仍发生了心血管原因导致的死亡,这强调了卡马西平过量可能产生延迟后果。治疗应包括积极洗胃并给予活性炭,在监测环境下提供全面支持治疗,并在患者出现低血压前考虑早期进行活性炭血液灌流。